Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo. Try Elite Free for 7 Days
Last Close
6.18
Aug 24 • 1:41 PM ET Dollar change-0.48 Percentage change(-7.21%)
Aug 21, 9:35 AMPMGC unit NorthStrive Biosciences files two U.S. patent applications for EL-22 and EL-32 in microgravity-induced muscle loss in humans
Index
-
Market Cap
5.00M
Enterprise Value
0.50M
Income
-13.50M
Sales
2.60M
Book/sh
2.72
Cash/sh
23.22
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
0.00%
Employees
32
IPO
Nov 21, 2023
P/E
-
Forward P/E
-
PEG
-
P/S
1.92
P/B
2.27
P/C
0.27
P/FCF
-
EV/EBITDA
-
EV/Sales
0.19
Quick Ratio
1.30
Current Ratio
1.40
Debt/Eq
0.86
LT Debt/Eq
0.27
Option/Short
No / Yes
EPS (ttm)
-1830.96
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
74.26% -
Sales past 3/5Y
-8.34% -
EPS Y/Y TTM
99.47%
Sales Y/Y TTM
-
EPS Q/Q
98.40%
Sales Q/Q
-
Insider Own
5.61%
Insider Trans
0.00%
Inst Own
3.29%
Inst Trans
-
ROA
-58.70%
ROE
-104.60%
ROIC
-68.30%
Gross Margin
-20.50%
Oper. Margin
-
Profit Margin
-
SMA20
-27.84%
SMA50
-41.20%
SMA200
-97.45%
Trades
Shs Outstand
0.81M
Shs Float
0.76M
52W High
3091.20 -99.80%
52W Low
5.40 14.44%
Volatility
23.20% 11.03%
ATR (14)
0.98
RSI (14)
29.37
Beta
-0.25
Rel Volume
0.44
Avg Volume
291.06K
Volume
84,178
Perf Week
-29.21%
Perf Month
-31.33%
Perf Quarter
-65.28%
Perf Half Y
-91.49%
Perf YTD
-98.26%
Perf Year
-99.69%
Perf 3Y
-
Perf 5Y
-
Perf 10Y
-
Recom
-
Target Price
-
Prev Close
6.66
Price
6.18
Change %
-7.21%
Aug-21-26 09:30AM
Aug-19-26 11:45AM
Aug-14-26 09:31AM
Jul-29-26 03:54PM
Jul-28-26 07:30AM
07:30AM Loading…
Jul-27-26 07:30AM
Jul-13-26 07:30AM
Jul-10-26 11:00AM
07:30AM
Jul-06-26 07:30AM
Jul-01-26 07:30AM
Jun-18-26 07:30AM
Jun-10-26 07:31AM
Jun-08-26 07:31AM
Jun-01-26 07:31AM
07:02AM Loading…
May-15-26 07:02AM
May-13-26 04:03AM
Apr-28-26 04:01PM
07:30AM
Apr-23-26 07:30AM
Apr-21-26 07:30AM
Apr-17-26 07:30AM
Apr-13-26 07:30AM
Apr-10-26 07:30AM
Apr-09-26 07:30AM
Apr-08-26 07:30AM
Apr-06-26 07:30AM
Apr-02-26 04:05PM
Mar-31-26 07:30AM
Mar-30-26 07:03AM
04:05PM Loading…
Mar-27-26 04:05PM
Mar-24-26 07:00AM
Mar-10-26 07:30AM
Mar-04-26 05:30PM
Feb-19-26 07:30AM
Feb-11-26 07:30AM
Feb-05-26 01:29PM
Feb-04-26 04:30PM
Feb-03-26 07:30AM
Jan-06-26 07:30AM
Jan-05-26 11:00PM
Jan-02-26 11:30AM
Dec-22-25 07:30AM
Dec-17-25 07:30AM
Dec-04-25 10:57AM
Oct-30-25 08:00AM
Oct-28-25 08:00AM
Oct-20-25 07:30AM
Sep-04-25 09:54AM
Aug-28-25 10:30AM
Aug-22-25 01:48PM
10:30AM
Aug-13-25 07:44AM
Jul-30-25 07:45AM
Jul-18-25 12:53PM
Jul-17-25 08:00AM
Jul-10-25 08:30AM
Jun-24-25 08:30AM
Jun-18-25 09:52AM
09:20AM
Jun-17-25 09:04AM
Jun-16-25 08:00AM
Jun-09-25 08:00AM
May-22-25 08:16AM
May-14-25 04:30PM
08:00AM
May-13-25 08:00AM
Apr-29-25 12:15PM
08:00AM
Apr-28-25 08:00AM
Apr-24-25 08:00AM
Apr-16-25 08:00AM
Apr-10-25 08:00AM
Mar-28-25 08:00AM
Mar-27-25 08:00AM
Mar-24-25 05:00PM
Mar-21-25 02:41PM
08:00AM
Mar-10-25 08:00AM
Mar-06-25 09:00AM
Feb-27-25 08:00AM
Feb-26-25 08:30AM
Feb-18-25 07:00AM
Feb-04-25 08:00AM
Jan-31-25 10:33AM
Jan-30-25 08:00AM
Jan-27-25 09:00AM
Jan-24-25 08:00AM
Jan-16-25 08:31AM
Jan-15-25 09:30AM
Jan-02-25 03:55PM
08:00AM
Dec-21-24 07:40AM
Dec-20-24 07:30PM
07:30AM
Dec-09-24 08:00AM
Dec-06-24 07:30AM
Dec-04-24 08:00AM
Nov-22-24 06:23PM
05:00PM
PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products. It operates through three segments: corporate, treasury and biosciences; IT packaging solutions; and precision engineering and machining. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also involved in the medical scientific research and development activities, as well as operating investment firms; providing packaging solutions to industrial and consumer markets; and design and production of high-tolerance components for industrial and technological applications. The company was formerly known as Elevai Labs, Inc. and changed its name to PMGC Holdings Inc. in December 2024. PMGC Holdings Inc. was incorporated in 2020 and is based in Newport Beach, California.
CEOMr. Graydon Bensler C.F.A.